OrganoClick AB (publ) Stock Nasdaq Stockholm
Equities
SE0006510335
Specialty Chemicals
Sales 2024 * | 166M 15.25M | Sales 2025 * | 148M 13.6M | Capitalization | 316M 29.07M |
---|---|---|---|---|---|
Net income 2024 * | -9M -827K | Net income 2025 * | 9M 827K | EV / Sales 2024 * | 2.18 x |
Net Debt 2024 * | 45M 4.13M | Net Debt 2025 * | 20M 1.84M | EV / Sales 2025 * | 2.27 x |
P/E ratio 2024 * |
-35.9
x | P/E ratio 2025 * |
35.9
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 60.61% |
Managers | Title | Age | Since |
---|---|---|---|
Mårten Hellberg
CEO | Chief Executive Officer | 44 | 05-12-31 |
Jessica Sundborg
DFI | Director of Finance/CFO | 42 | 12-12-31 |
Maria Wennman
CTO | Chief Tech/Sci/R&D Officer | 39 | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 65 | 15-12-31 | |
Håkan Gustavson
BRD | Director/Board Member | 66 | 15-12-31 |
Director/Board Member | 61 | 20-05-06 |
1st Jan change | Capi. | |
---|---|---|
+10.81% | 63.12B | |
+12.69% | 40.45B | |
+17.41% | 26.45B | |
+4.77% | 18.31B | |
-0.95% | 17.34B | |
-21.87% | 16.71B | |
+0.28% | 15.55B | |
-20.42% | 13.55B | |
+34.69% | 12.94B |